Biotech Stock’s alert – Gilead Sciences Inc, Dendreon Corporation, Arena Pharmaceuticals, Inovio Pharmaceuticals
Massapequa Park – March 27, 2013 — (Net PR News) – King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today, we bring a special trend analysis of the following stocks: Gilead Sciences, Inc. (NASDAQ:GILD), Dendreon Corporation (NASDAQ:DNDN), Arena Pharmaceuticals, Inc (NASDAQ:ARNA), Inovio Pharmaceuticals Inc (NYSEAMEX:INO)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Gilead Sciences, Inc. (NASDAQ:GILD) opened at the price of $46.20, along with 1.52 billion shares outstanding and touched its highest price of the day at $47.74 recently. The stock is trading at the price of $47.56 by scoring +3.92% at 3:24 PM.
The stock’s previous performance of one month showed that it gained almost 12.62%. In the previous 3 months it scored +31.29%. During its current trading session, the stock gained a volume of 15.47 million shares up-till now, which is higher than its average volume of 9.26 million shares. Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia.
Will GILD Continue To Move Higher? Find Out Here
Dendreon Corporation (NASDAQ:DNDN) stock recently hit its highest price at $4.88, starting its day trade with a price of $4.63 and reported an increase of 2.58%. Its most recent trading price was $4.78 at 3:28 PM. The 52 week price range of the company is $3.69 – $12.21, while today, up until 3:28 PM, its minimum price was $4.50. DNDN recently added a volume of 4.14 million shares, versus its average volume of 5.06 million shares. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
What was the Moving Force behind DNDN’s Bullish Run? Read This Research Report on DNDN
Arena Pharmaceuticals, Inc (NASDAQ:ARNA) remained among the bulls of the day during the early hours of trading, as it went up 2.22% recently. Beta value of the stock remained at 0.14 points, while its earnings per share was $-0.53.
During the last 5 day’s it gained 6.27%, while its last one month’s performance stands at 3.11%. The company’s traded volume is 2.99 million shares, as compared to its average volume of 5.53 million shares. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
For How Long will ARNA Attract Investors? Find out via this report
Inovio Pharmaceuticals Inc (NYSEAMEX:INO) is trading with a rise of 6.07%, along with the exchange price of $0.594 up till now, while its introductory price for today was $0.57.
Company’s 6 month’s performance gave a diminishing overview as it lost -1%, while in its last 5 days its performance remained in the green with the improvement of 16.47%. Today, up until 3:35p.m., its minimum price was $0.56. INO recently added a volume of 3.14 million shares, versus its average volume of 1.77 million shares. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases.
Why Should Investors Buy INO After The Recent Gain? Just Go Here and Find Out
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/